P. O. Gisleskog

发表

Use of Prior Information to Stabilize a Population Data Analysis

Mats O. Karlsson, Stuart L. Beal, M. Karlsson, 2002, Journal of Pharmacokinetics and Pharmacodynamics.

Bridging adults and paediatrics with secondary hyperparathyroidism receiving haemodialysis: a pharmacokinetic‐pharmacodynamic analysis of cinacalcet

Ping Chen, W. Sohn, P. O. Gisleskog, 2019, British journal of clinical pharmacology.

Population Pharmacokinetic and Pharmacodynamic Modeling of Etelcalcetide in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis

Benjamin Wu, J. Gibbs, A. Chow, 2017, Clinical Pharmacokinetics.

Rilotumumab Exposure–Response Relationship in Patients with Advanced or Metastatic Gastric Cancer

Yilong Zhang, S. Doshi, K. Oliner, 2015, Clinical Cancer Research.

Population pharmacokinetics of rilotumumab, a fully human monoclonal antibody against hepatocyte growth factor, in cancer patients.

J. P. Perez Ruixo, Yilong Zhang, S. Doshi, 2014, Journal of pharmaceutical sciences.

Exposure-response (E-R) analysis of rilotumumab (R, AMG 102) plus epirubicin/cisplatin/capecitabine (ECX) in patients (pts) with locally advanced or metastatic gastric or esophagogastric junction (G/EGJ) cancer.

R. Donehower, Yi-zhou Jiang, S. Doshi, 2012 .

Quantification of Radiation Injury on Neutropenia and the Link between Absolute Neutrophil Count Time Course and Overall Survival in Nonhuman Primates Treated with G-CSF

J. Pérez-Ruixo, J. Harrold, P. Jacqmin, 2020, Pharmaceutical Research.

A model for the turnover of dihydrotestosterone in the presence of the irreversible 5α‐reductase inhibitors GI198745 and finasteride

M O Karlsson, D. Hermann, M. Hammarlund-Udenaes, 1998, Clinical pharmacology and therapeutics.

An Exposure-Response Analysis of the Clinical Efficacy of Ponesimod in a Randomized Phase II Study in Patients with Multiple Sclerosis

J. Pérez-Ruixo, I. Poggesi, Tatiana Scherz, 2021, Clinical Pharmacokinetics.

Prediction of Survival Benefit of Filgrastim in Adult and Pediatric Patients With Acute Radiation Syndrome

J. Pérez-Ruixo, J. Harrold, P. Jacqmin, 2020, Clinical and translational science.

The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination.

M. Karlsson, D. Hermann, M. Hammarlund-Udenaes, 1999, British journal of clinical pharmacology.

Validation of a population pharmacokinetic/pharmacodynamic model for 5α-reductase inhibitors

M. Karlsson, D. Hermann, M. Hammarlund-Udenaes, 1999 .

Pharmacokinetics of Melagatran and the Effect on Ex Vivo Coagulation Time in Orthopaedic Surgery Patients Receiving Subcutaneous Melagatran and Oral Ximelagatran

B. Eriksson, M. Karlsson, J. Mandema, 2003, Clinical Pharmacokinetics.

Quantification of Radiation Injury on Neutropenia and the Link between Absolute Neutrophil Count Time Course and Overall Survival in Nonhuman Primates Treated with G-CSF

J. Pérez-Ruixo, J. Harrold, P. Jacqmin, 2020, Pharmaceutical Research.